stoxline Quote Chart Rank Option Currency Glossary
  
Edwards Lifesciences Corporation (EW)
87.77  0.77 (0.89%)    06-12 16:00
Open: 87.4
High: 89.03
Volume: 2,460,665
  
Pre. Close: 87
Low: 87.05
Market Cap: 52,890(M)
Technical analysis
2024-06-12 4:21:56 PM
Short term     
Mid term     
Targets 6-month :  104.14 1-year :  107.38
Resists First :  89.16 Second :  91.94
Pivot price 87.56
Supports First :  84.66 Second :  70.44
MAs MA(5) :  87.33 MA(20) :  88.15
MA(100) :  87.46 MA(250) :  80.66
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  23 D(3) :  24
RSI RSI(14): 50.4
52-week High :  96.12 Low :  60.56
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EW ] has closed below upper band by 44.3%. Bollinger Bands are 58% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 89.14 - 89.47 89.47 - 89.74
Low: 86.16 - 86.57 86.57 - 86.91
Close: 87.15 - 87.79 87.79 - 88.3
Company Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Headline News

Wed, 12 Jun 2024
Edwards Lifesciences executive sells $437,696 in stock By Investing.com - Investing.com

Wed, 12 Jun 2024
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Wed, 12 Jun 2024
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Wed, 12 Jun 2024
Edwards Lifesciences Co. (NYSE:EW) Shares Bought by Regal Investment Advisors LLC - Defense World

Wed, 12 Jun 2024
Connectus Wealth LLC Has $673000 Stake in Edwards Lifesciences Co. (NYSE:EW) - Defense World

Tue, 11 Jun 2024
Sei Investments Co. Purchases 54595 Shares of Edwards Lifesciences Co. (NYSE:EW) - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 603 (M)
Shares Float 597 (M)
Held by Insiders 0.8 (%)
Held by Institutions 84.7 (%)
Shares Short 8,000 (K)
Shares Short P.Month 7,380 (K)
Stock Financials
EPS 2.31
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 11.81
Profit Margin 23 %
Operating Margin 27.3 %
Return on Assets (ttm) 12 %
Return on Equity (ttm) 21.2 %
Qtrly Rev. Growth 9.5 %
Gross Profit (p.s.) 0
Sales Per Share 10.18
EBITDA (p.s.) 3.18
Qtrly Earnings Growth 3.5 %
Operating Cash Flow 528 (M)
Levered Free Cash Flow 672 (M)
Stock Valuations
PE Ratio 37.83
PEG Ratio 2.9
Price to Book value 7.42
Price to Sales 8.61
Price to Cash Flow 100.13
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android